Why the study?
Does a low serum albumin-to-creatinine ratio (sACR) predict pulmonary infection and adverse clinical outcomes in patients with STEMI undergoing PCI?
Does a low serum albumin-to-creatinine ratio (sACR) predict pulmonary infection and adverse clinical outcomes in patients with STEMI undergoing PCI?
Low serum albumin-to-creatinine ratio (sACR) is a novel prognostic marker for predicting pulmonary infection, in-hospital MACE, and mortality in STEMI patients undergoing PCI.
Low sACR was associated with higher infection, in-hospital MACE, and mortality in STEMI-PCI patients; hypothesis-generating and should not yet change practice.
A low sACR was significantly associated with elevated risk of pulmonary infection and MACE during hospitalization, as well as all-cause mortality during follow-up among patients with STEMI undergoing PCI. These findings highlighted sACR as an important prognostic marker in this patient population.
No takes yet. Share an insight, caveat, or question.
Kong et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: